Targeting Oncogenic Driver Mutations in Lung Cancer
Author(s): Matthew Lee , Fawzi Abu Rous , Alain Borczuk , Stephen Liu , Shirish Gadgeel , Balazs Halmos
Quantity
Pickup available at Cambridge University Press Bookshop
Usually ready in 24 hours
Targeting Oncogenic Driver Mutations in Lung Cancer
Cambridge University Press Bookshop
1-2 Trinity Street
Cambridge CB2 1SZ
United Kingdom
🚚 Please note we can only ship within the UK.
FREE delivery on books (excluding sale).
Delivery for other items is £1.50 - £4.50, calculated at checkout.
T&Cs apply.
Free click & collect on all orders.
The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
Choose options